ctrl K

Price Alert

Portage Biotech Inc. (PRTG)

NASDAQ: PRTG · Real-Time Price · USD

8.26

0.26 (3.25%)

At close: Aug 20, 2025, 9:35 AM

Portage Biotech Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	5.03M	10.54M	23.35M	2.77M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	2.89M	9.08M	9.14M
Other Long-Term Assets	49K	877K	36K	58K
Receivables	39K	682K	209K	683K
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	64K	119K	142K	n/a
Total Current Assets	7.7M	13.68M	24.83M	4.95M
Property-Plant & Equipment	35K	-2.63M	n/a	n/a
Goodwill & Intangibles	n/a	81.68M	160.71M	160.71M
Total Long-Term Assets	84K	85.45M	169.83M	169.91M
Total Assets	7.78M	99.13M	194.66M	174.86M
Account Payables	482K	274K	188K	113K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	150K
Other Current Liabilities	3K	n/a	72K	1.15M
Total Current Liabilities	2.88M	1.86M	783K	3.21M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1.56M	11.3M	n/a	n/a
Total Long-Term Liabilities	1.57M	21.87M	28.45M	24.05M
Total Liabilities	4.45M	23.73M	29.23M	27.26M
Total Debt	47K	n/a	n/a	150K
Common Stock	219.5M	218.78M	158.32M	130.65M
Retained Earnings	-239.32M	-159.62M	-55.01M	-38.13M
Comprehensive Income	23.84M	16.88M	958K	958K
Shareholders Equity	4.02M	76.05M	121.2M	101.45M
Total Investments	n/a	2.89M	9.08M	9.14M